Last updated: June 2026 · Reviewed June 2026 · Built by the InjectBuddy team
What Is Hematocrit? HCT ranges and the 54% Testosterone (TRT) line
Hematocrit (HCT) is the percentage of your blood volume made up of red blood cells — roughly 40–54% in adult men and 36–48% in adult women. It matters on testosterone replacement therapy (TRT) because testosterone reliably nudges that figure upward, and most guidelines treat a hematocrit above 54% as the line where the dose is paused. This guide covers what hematocrit measures, why TRT raises it, the action thresholds you need to know, the arithmetic behind the numbers, and the questions people ask most.
- Hematocrit = packed red-cell volume ÷ whole-blood volume, written as a percent (e.g. 0.47 = 47%).
- Typical reference: ~40–54% (men), ~36–48% (women); above the range is called erythrocytosis or polycythemia.
- Testosterone (TRT) raises HCT by stimulating erythropoietin and lowering hepcidin — a rise of a few points is common in the first 3–6 months.
- The Endocrine Society action threshold is HCT > 54%: pause testosterone, let it normalise, then resume at a lower dose.
- Planning a dose change? Run the numbers in the Testosterone (TRT) dose calculator so a smaller weekly amount or more frequent split is easy to compare.
What hematocrit actually measures
Spin a tube of blood in a centrifuge and it separates into layers: a heavy column of red cells at the bottom, a thin buffy coat of white cells and platelets, and straw-colored plasma on top. Hematocrit is simply the height of the red-cell column divided by the total column — the "packed cell volume" (PCV). A reading of 45% means red cells fill 45% of the tube and plasma plus everything else fills the other 55%.
Because it is a ratio, hematocrit tracks closely with haemoglobin (the oxygen-carrying protein inside red cells). A common rule of thumb is that hematocrit is roughly three times the haemoglobin value in g/dL — so haemoglobin of 15 g/dL pairs with a hematocrit near 45%. The number can drift up with dehydration (less plasma, so the red-cell fraction looks larger) or down with bleeding, which is why a single reading is read alongside the trend rather than in isolation.
Why Testosterone (TRT) raises hematocrit
Testosterone is one of the most predictable drivers of a rising hematocrit. It increases erythropoietin (EPO), the kidney hormone that tells bone marrow to make more red cells, and it suppresses hepcidin, freeing up iron for that production. In controlled studies, testosterone produced a 7–10% rise in haemoglobin and hematocrit, with EPO up about 58% and hepcidin down about 49% within the first month. The effect is dose-dependent: higher peaks — from large weekly injections or infrequent dosing — tend to push hematocrit higher than smaller, more frequent doses.
This is why injectable testosterone is monitored more closely than gels or pellets for this specific side effect. In a large matched-cohort analysis, testosterone cypionate injections raised hematocrit by about 4.4 percentage points on average, while intranasal testosterone slightly lowered it. The rise is usually gradual and reversible — but a hematocrit climbing past the reference range thickens the blood (hyperviscosity) and is the reason monitoring is built into every Testosterone (TRT) protocol.
HCT ranges and Testosterone (TRT) action thresholds
The table below pairs common hematocrit bands with how they are usually read on Testosterone (TRT). These are general reference figures — your laboratory prints its own range and your prescriber sets your target.
| Hematocrit (%) | Label | Typical Testosterone (TRT) reading |
|---|---|---|
| < 36 (M) / < 33 (F) | Low / anaemic range | Investigate; not caused by testosterone |
| 40–54 (M) | Normal male range | Within range — routine monitoring |
| 36–48 (F) | Normal female range | Within range — routine monitoring |
| 50–52 | High-normal / borderline | Watch closely; review dose and frequency |
| 52–54 | Mild erythrocytosis | Often prompts a dose or frequency review |
| > 54 | Erythrocytosis (action line) | Guideline threshold to pause testosterone |
The headline figure to remember is 54%. The 2018 Endocrine Society guideline recommends withholding testosterone when hematocrit exceeds 54%, waiting for it to fall back into range, and then resuming at a lower dose — sometimes alongside therapeutic phlebotomy (a controlled blood draw). It also recommends a baseline hematocrit before starting, then checks at roughly 3, 6 and 12 months.
How this is calculated
Two pieces of hematocrit arithmetic come up constantly, and both are plain subtraction or division — no calculator required, though the worked examples below show the steps.
Absolute change (percentage points): new HCT minus old HCT. Going from 46% to 52% is a 6 percentage-point rise. Relative change (percent): divide the point change by the starting value, then multiply by 100. The same 46% → 52% move is (6 ÷ 46) × 100 = 13.0% higher than baseline. Reports often quote the point change because the 54% threshold is itself a point value, not a relative one.
Threshold headroom: 54 minus your current reading tells you how many points of margin remain before the action line. A reading of 49% leaves 5 points; a reading of 53% leaves just 1. The figure helps decide whether a dose tweak is urgent or simply worth watching at the next blood test.
Worked examples
Baseline HCT 46%, repeat at 6 months 52%. Change = 52 − 46 = +6 percentage points. Still below 54%, so within range but trending up.
Same 46% → 52% move as a percentage: (6 ÷ 46) × 100 = 13.0% higher than baseline.
Current HCT 53%. Is it over the action line? 53 < 54, so below threshold — but only 54 − 53 = 1 point of headroom remains.
Current HCT 55%. 55 > 54, so it is over the 54% action line by 1 point — the reading most guidelines flag for pausing testosterone.
A lab reports hematocrit as the fraction 0.48. Multiply by 100: 0.48 × 100 = 48%. Same number, different notation.
Current HCT 49%, threshold 54%. Remaining margin = 54 − 49 = 5 points — comfortable, so routine re-check rather than urgent action.
Haemoglobin 15 g/dL, using the ×3 rule of thumb: 15 × 3 = ~45% expected hematocrit. A printed HCT far from this prompts a re-read.
How hematocrit is monitored on Testosterone (TRT)
A practical monitoring loop looks like this: get a baseline hematocrit before the first injection, recheck at about 3, 6 and 12 months, then at least yearly once stable. If a reading drifts into the 52–54% borderline, the usual levers are lowering the weekly dose, splitting it into smaller more frequent injections to flatten peaks, improving hydration before the blood draw, and addressing sleep apnoea or smoking, which independently raise red-cell counts. If hematocrit crosses 54%, testosterone is paused and a clinician decides on phlebotomy or blood donation.
None of these are decisions to make alone from a calculator. Hematocrit interpretation belongs with a prescriber who can see the full panel, your symptoms and your history — this guide is the maths and the context, not medical advice.
So, what is hematocrit?
Hematocrit is the percentage of your blood that is made up of red blood cells — the packed red-cell volume divided by whole-blood volume, expressed as a percent. The normal range is roughly 40–54% for adult men and 36–48% for adult women. On testosterone replacement therapy, that figure tends to climb because testosterone stimulates erythropoietin and suppresses hepcidin, both of which drive red-cell production; the widely used action threshold is HCT above 54%, at which point most guidelines recommend pausing testosterone until it normalises. Use the Testosterone (TRT) dose calculator to compare smaller or more frequent doses that may help keep hematocrit in check.
FAQs
What is hematocrit?
What hematocrit is too high on Testosterone (TRT)?
Why does testosterone raise hematocrit?
Is hematocrit the same as haemoglobin?
Can dehydration change my hematocrit reading?
Sources
- Bhasin S, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018. PubMed PMID: 29562364. (HCT > 54% action threshold; baseline + 3/6/12-month monitoring.)
- Mondal H, Zubair M. Hematocrit. StatPearls. 2024. NCBI Bookshelf NBK542276. (Definition and normal ranges 40–54% male, 36–48% female.)
- Ratan P, et al. Testosterone use causing erythrocytosis. CMAJ. 2017. PMC5647167. (TRT raised HCT 46% → 58%; discontinue above 54%.)
- Bachman E, et al. Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin. J Gerontol A Biol Sci Med Sci. 2014. PMC4022090. (Mechanism: EPO up, hepcidin down.)
- Lee G, Choi WS, et al. Polycythemia. StatPearls. 2023. NCBI Bookshelf NBK526081. (Erythrocytosis defined by raised HCT; testosterone a secondary cause.)
This guide is for general educational purposes only and does not constitute medical advice. Hematocrit results and Testosterone (TRT) dose changes must be interpreted by your prescriber. Always follow your clinician's specific instructions.